Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7341 p334-335
19 March 2005

This article
Reprint   Photocopy

PDF 90K, Acrobat Reader

Letters

· Public liability insurance
· Community pharmacy
· New contract
· Council election
· Prescription charges
· Repeat dispensing
· ETP
· Complementary medicine
· The Society (4)
· The Journal (2)


Letters to the Editor

Community pharmacy

Laxity of personal control is not a panacea for the public

From Mr B. D. Nathwani, MRPharmS

The paper, “Making the best use of the pharmacy workforce — a consultation paper”, is a red herring full of Whitehall doublespeak and unsupported statements. But its potential relevance in terms of the pay and conditions for pharmacists, and for the safety and accessibility of pharmaceutical services, should not be underestimated. For all the document’s purported vision, the reality could be that, in the long term, immediate and full face-to-face access to a pharmacist will disappear.

The paper alleges that there is a pharmacist shortage being filled by locums. It misses the point that many choose to work as locums for a variety of reasons and fails to enquire why. Will remote supervision and lax personal control remove the problem of pharmacists choosing to work as locums rather than as employees?

The paper goes on to declare that access to emergency hormonal contraception and counselling will be improved and glibly states that “patient safety must remain paramount at all times”. Will remote supervision and lax personal control enhance the immediate face-to-face access and counselling that the public enjoys at the moment?

Is it fair to hold pharmacists professionally responsible for work carried out in their absence using standard operating procedures?

The paper also states that to employ a technician costs circa £25,000 as compared with £40,000 for a pharmacist. The new contract will review employment costs for dispensing and other services. It is not rocket science to determine what will happen next. While we as citizens should applaud the Government for delivering services at a reduced cost to us as taxpayers, we also need to consider whether the new service is a like-for-like replacement.

Small independent pharmacies need to be especially wary as they are more likely to carry out services and dispensing single-handedly. The threat to the employment opportunities of employee pharmacists is also significant. Once cost enquiries show that technicians can displace pharmacists in the dispensing processes the remuneration for dispensing services will fall drastically. This is why the new contract still favours volume dispensing because volume, as opposed to service quality, is easily measured and thus volume payments are easier to cut at a future date.

I support minor changes to personal control to help all pharmacists deliver the new services within the new contract. However, wholesale changes to supervision and laxity of personal control are not a panacea for pharmacy or the public.

Bharat Nathwani
Council election candidate
Pinner, Middlesex

Send your letter to The Editor

Previous Topic (Public liability insurance)
Next Topic (New contract)

Back to Top


©The Pharmaceutical Journal